Literature DB >> 29339088

Retinal neuronal cell loss prevents abnormal retinal vascular growth in a rat model of retinopathy of prematurity.

Ayuki Nakano1, Daiki Asano1, Ryo Kondo1, Asami Mori1, Shiho Arima2, Hiroko Ushikubo1, Kenji Sakamoto1, Tohru Nagamitsu2, Kunio Ishii1, Tsutomu Nakahara3.   

Abstract

A short-term blockade of the vascular endothelial growth factor (VEGF)-mediated pathway in neonatal rats results in formation of severe retinopathy of prematurity (ROP)-like retinal blood vessels. The present study aimed to examine the role of retinal neurons in the formation of abnormal retinal blood vessels. Newborn rats were treated subcutaneously with the VEGF receptor tyrosine kinase inhibitor, KRN633 (10 mg/kg), or its vehicle (0.5% methylcellulose in water) on postnatal day (P) 7 and P8. To induce excitotoxic loss of retinal neurons, N-methyl-D-aspartic acid (NMDA) was injected into the vitreous chamber of the eye on P9. Changes in retinal morphology, blood vessels, and proliferative status of vascular cells were evaluated on P11 and P14. The number of cells in the ganglion cell layer and the thickness of the inner plexiform layer and inner nuclear layer were significantly decreased 2 days (P11) after NMDA treatment. The pattern and degree of NMDA-induced changes in retinal morphology were similar between vehicle-treated (control) and KRN633-treated (ROP) rats. In ROP rats, increases in the density of capillaries, the tortuosity index of arteries, and the proliferating vascular cells were observed on P14. The expansion of the endothelial cell network was prevented, and the capillary density and the number of proliferating cells were reduced in NMDA-treated retinas of both control and ROP rats. Following NMDA-induced neuronal cell loss, no ROP-like blood vessels were observed in the retinas. These results suggest that retinal neurons play an important role in the formation of normal and ROP-like retinal blood vessels.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Abnormal retinal vascular growth; Retinal ganglion cells; Retinopathy of prematurity; Vascular endothelial growth factor; Vascular endothelial growth factor receptor tyrosine kinase inhibitor

Mesh:

Substances:

Year:  2018        PMID: 29339088     DOI: 10.1016/j.exer.2017.12.007

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  3 in total

Review 1.  Neurovascular abnormalities in retinopathy of prematurity and emerging therapies.

Authors:  Chang Dai; Jun Xiao; Chenguang Wang; Wei Li; Guanfang Su
Journal:  J Mol Med (Berl)       Date:  2022-04-08       Impact factor: 5.606

2.  Cellular Mechanisms of Angiogenesis in Neonatal Rat Models of Retinal Neurodegeneration.

Authors:  Daiki Asano; Masaki Hokazono; Shogo Hirano; Akane Morita; Tsutomu Nakahara
Journal:  Int J Mol Sci       Date:  2019-09-25       Impact factor: 5.923

3.  Extract of the Blood Circulation-Promoting Recipe-84 Can Protect Rat Retinas by Inhibiting the β-Catenin Signaling Pathway.

Authors:  Qiu-Fang Qin; Min Liu; Gui-Hua Tian; Jian Chen; Yu-Sang Li
Journal:  Int J Mol Sci       Date:  2018-09-11       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.